通过WT1抑制SGK1可能会在压力条件下为白血病细胞提供生存优势
Miguel A Rubio1, Sabina Cisa-Wieczorek1, Ana Mozos2
1Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.
Annals of hematology
|July 4, 2025
概括
威尔姆斯瘤1 (WT1) 调节了急性髓性白血病 (AML) 中的血清和葡萄糖皮质体诱导的激酶1 (SGK1). 这种WT1-SGK1相互作用会影响白血病细胞活力和亡,这表明AML的新型治疗点.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 威尔姆斯瘤1 (WT1) mRNA在急性髓性白血病 (AML) 中升高,并作为白血病负担的标记物.
- WT1在调节白血病细胞行为的精确作用及其下游点在很大程度上仍未被描述.
研究的目的:
- 为了识别AML中由WT1调节的基因.
- 研究WT1及其潜在点基因SGK1在AML中的功能关系.
主要方法:
- 对具有不同WT1mRNA水平的AML样本进行基因表达阵列分析.
- 细胞模型评估WT1调制对SGK1表达和活性的影响.
- 报告员试图评估WT1对SGK1促进者的影响.
主要成果:
- 在AML细胞系和患者样本中观察到WT1和SGK1mRNA水平之间的反相关性.
- 过度表达WT1降低了SGK1的表达,而WT1的淘汰增加了它,表明WT1抑制了SGK1.
- 在营养缺乏的情况下,WT1的淘汰降低了细胞活力,而SGK1的抑制在血清饥饿期间增强了对亡的抵抗力.
结论:
- 在AML中,WT1负面调节SGK1的表达.
- WT1和SGK1之间的相互作用影响了白血病细胞的存活率和应对压力条件的反应.
- 向SGK1可能为血液性恶性瘤提供治疗策略,需要进一步调查.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Canonical Wnt Signaling Pathway
9.0K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.0K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Replicative Cell Senescence
3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K


